Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “et-”

14 pharma patents match "et-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 14
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 14 pharmaceutical patents matching "et-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

14 results for “et-” · 30,257 patents in full index Clear search

  1. US 12116416

    Targeting intracellular target-binding determinants with intracellular antibodies

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted

  2. US 11224577

    Treating infection by a platelet-targeting microbe using nanoparticles

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  3. US 10683363

    Targeting intracellular target-binding determinants with intracellular antibodies

    The United States of America as represented by the Department of Veteran Affairs · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  4. US 10507284

    Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type I diabetes applications

    The Regents of the University of California · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted

  5. US 10500167

    Droplet-embedded microfibers, and methods and devices for preparing and using same

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  6. US 10450358

    Platelet-derived growth factor B mutant, preparation method therefor and use thereof

    Institute of Biotechnology, Academy of Military Medical Sciences, China · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  7. US 9751932

    Anti-big-endothelin-1 (big-ET-1) antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

  8. US 9663790

    Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted May 30, 2017 · Expires May 25, 2037

    granted

  9. US 9427469

    Soluble physiological chitosan formulations combined with platelet-rich plasma (PRP) for tissue repair

    ORTHO REGENERATIVE TECHNOLOGIES INC. · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

  10. US 8808735

    Fast wet-massing method for the preparation of calcium-containing compositions

    TAKEDA NYCOMED AS · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  11. US 8349568

    Method of diagnosing poor survival prognosis colon cancer using let-7g

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  12. EP 2064340

    VERFAHREN ZUR BEWERTUNG VON PATIENTEN BEI DER BEHANDLUNG MIT AUF RET-REZEPTOR-TYROSINKINASE ABZIELENDEN ARZNEISTOFFEN

    ASTRAZENECA AB [SE] · Granted Jun 3, 2009 · Expires May 29, 2029

    granted

  13. US 6660488

    Antibodies for the alpha platelet-derived growth factor receptor

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 9, 2003 · Expires Dec 4, 2023

    expired

  14. US 6228600

    Immunoassays for the alpha platelet-derived growth factor receptor

    The United States of America, as represented by the Department of Health and Human Services · Granted May 8, 2001 · Expires May 3, 2021

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.